Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 9, 2012, after the close
10-Q filed Aug 9, 2012, 40 days after period end · 0001144204-12-044017
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $78.13K | $0.00 | — |
| Net Income | -$2.38M | -$3.65M | -$4.95M |
| EPS Diluted | -$0.04 | -$0.08 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
